SciTransfer
Organization

UNIVERSITY OF CENTRAL FLORIDA

Major US research university contributing to European MSCA programmes across pharmaceutical sciences, coastal risk modelling, and social inclusion.

University research groupmultidisciplinaryUSThin data (2/5)
H2020 projects
4
As coordinator
0
Total EC funding
Unique partners
36
What they do

Their core work

The University of Central Florida is a large US public research university based in Orlando, Florida, participating in European research through Marie Skłodowska-Curie staff exchange and fellowship programmes. Their H2020 involvement spans pharmaceutical sciences (drug delivery, biopharmaceutics), quantum physics, social sciences around mega sports events, and coastal hazard modelling. UCF contributes as a third-party partner, providing US-based research capacity and transatlantic knowledge exchange rather than leading EU consortia directly.

Core expertise

What they specialise in

Quantum wave physicssecondary
1 project

NHQWAVE project on non-Hermitian quantum wave engineering (2016-2020).

Coastal hazard risk modellingemerging
1 project

SpaDeRisks project (2022-2025) on spatial dependencies of storm surges and global flood risk assessment.

Sport, human rights, and social inclusionemerging
1 project

EventRights project addressing inequality, diversity, and human rights in hosting mega sports events.

Evolution & trajectory

How they've shifted over time

Early focus
Pharma and quantum physics
Recent focus
Social inclusion and coastal risk

UCF's early H2020 engagement (2016-2018) centred on hard sciences — quantum physics and pharmaceutical technology including drug delivery, biopharmaceutics, and medicinal chemistry. Their more recent projects (2018-2024) shifted markedly toward applied social science and environmental risk, covering mega sports event governance, human rights, and coastal flooding models. This diversification suggests UCF's European engagement draws from multiple faculties rather than a single research group.

UCF's H2020 portfolio is broadening from hard sciences toward environmental and social science topics, suggesting growing interest in interdisciplinary transatlantic collaboration.

Collaboration profile

How they like to work

Role: third_party_expertReach: Global17 countries collaborated

UCF participates exclusively as a third-party partner — never as coordinator or even a direct consortium member. This is typical for non-EU institutions joining MSCA exchange programmes to provide complementary expertise and host visiting researchers. Despite only four projects, they have connected with 36 unique partners across 17 countries, indicating they serve as a valued transatlantic node rather than a deep repeat collaborator with specific European groups.

UCF has collaborated with 36 unique partners spanning 17 countries through just 4 MSCA projects, reflecting the large consortium sizes typical of MSCA-RISE actions. Their network is geographically broad, connecting European institutions with US-based research capacity.

Why partner with them

What sets them apart

As a major US research university, UCF offers European consortia a transatlantic bridge — access to American research infrastructure, student talent, and a non-EU perspective that MSCA programmes specifically encourage. Their topical breadth across pharma, physics, social science, and environmental modelling means they can contribute to diverse consortium needs. For European coordinators, UCF is a proven third-country partner familiar with H2020 programme requirements.

Notable projects

Highlights from their portfolio

  • ORBIS
    Comprehensive biopharmaceutical internship programme covering the full drug development pipeline from medicinal chemistry to dissolution and biomedical analysis.
  • SpaDeRisks
    Most recent project (2022-2025) tackling global storm surge risk — positions UCF in the growing climate adaptation research space.
Cross-sector capabilities
healthenvironmentsociety
Analysis note: Profile based on only 4 projects, all as third-party participant with no reported EC funding. The topical spread across unrelated fields suggests involvement from separate UCF departments rather than a coherent institutional strategy toward EU programmes. Limited data makes it difficult to identify a dominant research identity within H2020.